Chengdu Easton Biopharmaceuticals (688513.SH): Injection of Vecuronium Bromide obtains Drug Registration Certificate.
Yuandong Biotech (688513.SH) announced that the company has recently received the approval and issuance of the "Drug... by the National Medical Products Administration.
Chengdu Easton Biopharmaceuticals (688513.SH) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration. The drug is named Injection Vecuronium Bromide, with the main ingredient being Vecuronium Bromide. Indications: mainly used as an adjuvant for general anesthesia, for endotracheal intubation during general anesthesia and muscle relaxation during surgery.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
